Three Chinese drugmakers are under investigation for crimes including using counterfeit medicines, the industry watchdog said, as China cracks down on shoddy practices in the world’s second-biggest drugs market. The China Food and Drug Administration said it was investigating Hebei Yongfeng Yaoye, a subsidiary of Hong Kong-listed CSPC Pharmaceutical Group, as well as Gansu Dadeli Pharmaceutical and Guizhou Shouxian Pharmaceutical. China is pushing an ambitious program of healthcare reforms to improve its home-made medicines, and has vowed to crack down on poor quality drugs.
Continued here:
China probes drugmakers over production methods